ASX:RGS - Regeneus AGC Agreement termination paves way for commercial partner

Monday, January 6, 2020 2:00 AM +00:00

ASX:RGS - Regeneus AGC Agreement termination ...0:008:47
LIVEQuality1  AudioSubtitleDownloadSpeed1  
REGENEUS LTD
Leo Lee

Regeneus Ltd (ASX: RGS) a clinical-stage regenerative medicine company, has come to a mutual agreement with Japan-based manufacturer AGC Inc (AGC) to terminate their exclusive manufacturing licence and joint venture agreement.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 16 Mar

    02:00

    Working Together During Coronavirus Outbreak

    CISCO SYSTEMS
  • 16 Mar

    02:00

    FYI Resources DFS highlights low capital and operating costs for kaolin and HPA project

    FYI RESOURCES LIMITED
  • 16 Mar

    02:00

    Eli Lilly CEO talks partnering with AbCellera Biologics to co-develop a coronavirus cure 14.03.2020

    ELI LILLY AND COMPANY
  • 16 Mar

    02:00

    amaysim Australia Ltd (AYS) CEO & Managing Director, Peter O’Connell 11.03.2020

    AMAYSIM AUSTRALIA LIMITED
  • 16 Mar

    02:00

    2021 Ford Mustang Mach-E: Winter Testing All-Wheel Drive | Ford 13.03.2020

    FORD MOTOR COMPANY